Professor Mark Mamula (Yale University) provides an update on the EGFR/HER2 "Yale" vaccine cancer treatment for dogs. This immunotherapy targets EGFR and HER2 proteins and has demonstrated promising results in treating dogs with osteosarcoma and hemangiosarcoma.

The body’s immune system runs on a circadian rhythm, meaning the timing of treatments like immunotherapy or vaccines can influence how well they work. Studies in humans and animals show that morning administration often leads to stronger immune responses and better survival outcomes, a finding now being explored for canine cancer care.

Learn more about Elias Cancer Immunotherapy (ECI), a newly USDA-approved treatment for dogs with osteosarcoma. It explains how ECI works, its benefits, success rates, costs, and availability for families seeking new options in canine cancer care.

Dr. Jeffrey Bryan of the University of Missouri explains how the Elias Cancer Immunotherapy works, what the response rates look like, and the types of canine cancers it may treat. He also addresses eligibility, access, and potential side effects.

EGFR vaccine helped Dennis overcome osteosarcoma without losing his leg.

List of new immunotherapy treatments for dogs with osteosarcoma. Immunotherapy treatments may give dogs a chance for longer remission and survival, compared to standard therapies alone (e.g. surgery plus chemotherapy)

New treatment options for hemangiosarcoma.

Immunocidin may be a gentler alternative to chemotherapy, according to Max's mom.

Prof Mark Mamula (Yale School of Medicine) joined us for a webinar, during which he shared updates about the EGFR/HER2 Canine Cancer...

When I first learned about a new cancer vaccine that might reduce the risk for many aggressive canine cancers, I wanted to sign up our...

What can be done to help more dogs respond to cancer immunotherapy? One answer might be combination immunotherapy.

Understanding canine sarcoma and treatment options

July 6, 2023 update on EGFR/HER2 canine cancer vaccine from the research team, including the updated enrollment criteria.

Gut microbiome can impact cancer treatment efficacy and side-effects. It can also decrease (or increase) risk for cancer.

Almost three years after her diagnosis, Maggie is still cancer-free.

A new vaccine based immunotherapy is helping some dogs attain long-term cancer remissions.

Prof. Mamula provides a summary of his work on EGFR-peptide vaccine to treat a range of canine cancers, including osteosarcoma.

The tumor is resolved ... GONE!

Cancer immunotherapy helps the dog's own immune system fight cancer cells and has the potential for inducing long-term remission.